Medical Science Team Lead. R&D, medical communications. VISFO is a health-tech consultancy providing strategic intelligence and custom SaaS to the pharmaceutical, healthcare, consumer health and academic sectors.

Commercial Team. Preclinical and clinical strategy input, commercial opportunity analysis, biomedical literature review, partner relations, preparation of written and visual communications materials for a variety of audiences including media representatives, general public, potential partners, collaborators, governance bodies and other stakeholders. Social and website media content. Preparation of proposals for financial support from government and external funding initiatives and investors.

R&D Team. Biological authority in a multidisciplinary group of engineers, chemists, physicists. Led the design and resourcing of preclinical programme to test Microwearable sensors in an animal model in collaboration with ANU colleagues, gaining ethical approval. Developed various ex vivo models for in-house testing. Managed in-house laboratory resourcing. Produced written/visual marketing materials to highlight our technology to various partners and the general public. Contribution to/management of to successful large funding applications. Contributed to website design and commercial team activities.

R&D Team. Development of wearable sensors for minimally invasive continuous biomarker monitoring.Establishment and early testing of in vitro protocols for functionalising 'Microwearable' sensors for target specificity using biological sensing elements. Troponin monitoring for early detection of myocardial infarction. Establishment of ex vivo models for preclinical proof-of-concept. Design and resourcing of dedicated on-site laboratory facility. Working alongside engineering colleagues to characterise Microwearable skin engagement characteristics.

Novel dendritic cell-targeting immunotherapies for cancer.Developing cutting-edge models of the human immune system to evaluate new treatment strategies for blood and solid cancers. Targeting specific, rare subsets of immune cells to elicit potent anti-tumour T cell responses. New generation models of melanoma to test cancer immunotherapies. Fourth generation lentiviral systems to modify immune cells, humanised mice, human stem cell culture. International and national oral presentation of results, supervision of undergraduate and postgraduate students. Active member of Mater Early Career Researcher Committee, TRI Science Business Inspiration Forum, Mater Higher Research Degree ECR rep and Brisbane Life Science Symposium Committee. Organised several events to celebrate International Day of Immunology. Aus Soc Immunol membership.

Tuition of students in biomedical subjects as part of the UQ Indigenous Tutorial Assistance and Retention Scheme.

Microneedle skin patch vaccine delivery.Immunological projects focussing on minimally invasive vaccine delivery using a patch (now being commercialised by Vaxxas Pty). Microneedle-induced cell death as a 'physical adjuvant'. Experimental malaria vaccines (supported by Bill & Melinda Gates Foundation), polio (WHO), pneumococcal vaccine, influenza vaccine, RSV vaccine. Established formulation for long-term stability of Nanopatch-coated live viral vector vaccines, removing need for refrigeration. Supervised numerous students from high school to PhD. Established and maintained international collaborations. Outreach activities (educational and recruitment) activities as an AIBN Ambassador.

Needle-free mucosal delivery of vaccines and microbicides.Facilitating team of research-active NHS clinicians. Writing protocols and clinical trial documentation, grant seeking. Laboratory sample preparation for a Phase I trial of a mucosal vaccine. Participation in a EU Framework 7 HIV vaccine collaboration.

Internship in the Malaria Immunology Laboratory under Dr Jamila Ismaili. Analysing malaria-specific antibody and T cell responses across age and ethnic groups in study participants.